Document is current
Any future updates will be listed below
-
Authors
Hoyler, Ameli
Rieger, Oliver
Hackelöer, Max
Neznansky, Mark
Henrich, Wolfgang
Lorenz-Meyer, Lisa
Verlohren, Stefan
-
Funding
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 5 October 2025
Accepted: 4 December 2025
First Online: 6 February 2026
Declarations
:
: Stefan Verlohren has received speaker fees and/or serves on advisory boards for Beech Biopharma, Comanche Biopharma, Neopredics, ThermoFisher and Roche Diagnostics. Stefan Verlohren holds stock options on Neopredics. All other authors declare to not have a conflict of interest.
: This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Ethics Committee of Charité –Universitätsmedizin Berlin approved this study, approval number EA2/064/20.
: This was a retrospective real-world study on patient data from patients hospitalized at Charité – Universitätsmedizin Berlin. An individual consent to participate was not obtained.
